Rare mutations in the telomerase reverse transcriptase (TERT) promoter may arise in NAFLD–cirrhosis, in 10–20% of both low-grade and high-grade dysplastic nodules and in familial HCC, suggesting that TERT germline genetic variants may be involved in tumor initiation [227]. Here, TERT is linked to hepatocellular carcinoma.